Clinical Trials

55 enrolled

Carcinoma, Basal Cell

NCT02874430 2026-04-22

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Phase 2 Terminated

29 enrolled 11 charts

Breast Neoplasms

NCT02974647 2026-04-22

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

83 enrolled

Lymphoma, Recurrence

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

40 enrolled 22 charts

Resectable Pancreatic Cancer

NCT03436654 2026-04-22

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

102 enrolled

Genitourinary

Prostatic Neoplasms

NCT03481114 2026-04-22

REPAINT

55 enrolled 19 charts

Carcinoma, Non-Small-Cell Lung

NCT03981146 2026-04-22

ANICCA

35 enrolled 15 charts

Colorectal Neoplasms

NCT04049331 2026-04-22

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

240 enrolled

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

NCT04080804 2026-04-22

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

80 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

42 enrolled

CNS

Meningioma

NCT04701307 2026-04-22

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

48 enrolled

EndocrineThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT04837820 2026-04-22

The Effect of Acupuncture on Cancer-Related Cognitive Difficulties

270 enrolled

Breast Neoplasms

NCT04891289 2026-04-22

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

164 enrolled

Cholangiocarcinoma

NCT04917809 2026-04-22

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

20 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05507541 2026-04-22

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

10 enrolled

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05583708 2026-04-22

iPRRT

18 enrolled

Carcinoma, Merkel Cell

NCT05655949 2026-04-22

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Bile Duct Neoplasms, Cholangiocarcinoma

NCT05843253 2026-04-22

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

120 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT05972135 2026-04-22

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

100 enrolled

Plasma cell

Cytokine Release Syndrome, Multiple Myeloma

NCT06027268 2026-04-22

ToPCourT

36 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT06180356 2026-04-22

ANALLISA

Gynecologic

Ovarian Neoplasms

NCT06423326 2026-04-22

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

36 enrolled

Pancreatic Neoplasms

NCT06528691 2026-04-22

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

52 enrolled

CNS

Glioma, Central Nervous System Neoplasms

NCT06599762 2026-04-22

MYELO-CAN:TXA

Classical hematologyMyeloidOther hematologic neoplasm

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT06773910 2026-04-22

TIGOS-LS

250 enrolled

Limited Stage Small Cell Lung Cancer

NCT06839053 2026-04-22

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT06948786 2026-04-22

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

22 enrolled

Lymphoma, Follicular

NCT06961084 2026-04-22

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

62 enrolled

Thyroid Neoplasms

NCT07057791 2026-04-22

PrE0510

60 enrolled

Small Cell Lung Carcinoma

NCT07069595 2026-04-22

PREDICT-RD

78 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07123649 2026-04-22

I-MAMMO

364 enrolled

Breast Neoplasms

NCT07226453 2026-04-22

PNOC041

Posterior Fossa Ependymal Tumor

NCT07353684 2026-04-22

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

49 enrolled

Adebrelimab

NCT07527325 2026-04-22

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

35 enrolled

Melanoma

NCT07528417 2026-04-22

MYELO-CAN:ABX

MyeloidOther hematologic neoplasm

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07543783 2026-04-22

Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAIC

38 enrolled

Carcinoma, Hepatocellular

NCT07543848 2026-04-22

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

20 enrolled

Rectal Neoplasms

NCT07544784 2026-04-22

APSOC

73 enrolled

Colorectal Cancer Liver Metastases (CRLM)

NCT07545083 2026-04-22

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC)

26 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07545213 2026-04-22

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07545720 2026-04-22

Pinoxin for the Prevention of Radiation-Induced Skin Injury

202 enrolled

Cancer Patients Undergoning Radiotherapy

NCT07545746 2026-04-22

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

140 enrolled

Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT01816971 2026-04-21

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

76 enrolled 12 charts

Plasma cell

Multiple Myeloma

NCT02957968 2026-04-21

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

46 enrolled 21 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03149029 2026-04-21

Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma

16 enrolled 10 charts

Melanoma

NCT03389477 2026-04-21

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

26 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck

NCT03483012 2026-04-21

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

6 enrolled 19 charts

Breast Neoplasms

NCT03623373 2026-04-21

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

13 enrolled 13 charts

Lymphoma, Mantle-Cell

NCT03872661 2026-04-21

NIBCUN

36 enrolled